Abnormal SUMOylation may cause changes in subcellular localization and the stability and transcriptional activity of TFEB proteins [29], ultimately leading to cardiovascular disease, metabolic disease, neurodegenerative disease, and tumors [18]. Here, TFEB is linked to cardiovascular disorder.